Policy Recommendations to Support Equitable Access to Long-Acting Injectables for Human Immunodeficiency Virus Prevention and Treatment: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association

By sjmartinez • January 29, 2025

Marcus JL, Weddle A, Kelley CF, Agwu A, Montalvo S, Sherman E, Vijayan T, Gutierrez J, Hickey MD, Dilworth SE, Krakower D, Davis TL, Collins LF, McNulty MC, Colasanti JA, Christopoulos KA. Policy Recommendations to Support Equitable Access to Long-Acting Injectables for Human Immunodeficiency Virus Prevention and Treatment: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association. Clin Infect Dis. 2025 Jan 28:ciae648. doi: 10.1093/cid/ciae648. Epub ahead of print. PMID: 39873495.

Tags: antiretroviral agents, Cabotegravir, Health policy, Infectious Diseases, lenacapavir, Pre-exposure prophylaxis, Publications

Factors Affecting Risk of Cardiovascular Disease (CVD) Events in a Global CVD Prevention Cohort of People With HIV

Grinspoon SK, Watanabe M, Ribaudo HJ, Bloomfield GS, Fichtenbaum CJ, Umbleja T, Chu SM, Fitch KV, Diggs MR, Zhao S, Looby SE, Currier JS, Aberg[...]

Adjunctive GM-CSF therapy enhances host defense against systemic Candida auris infection in immunosuppressed mice

Mattos EC, Das Gupta K, Quintanilla D, Hautau H, Ibrahim AS, Singh S. Adjunctive GM-CSF therapy enhances host defense against systemic Candida auris infection in immunosuppressed mice.[...]

The path ahead: Building community between palliative care and infectious disease teams

Karlin D, Vijayan T. The path ahead: Building community between palliative care and infectious disease teams. Clin Microbiol Infect. 2026 Feb 2:S1198-743X(26)00034-0. doi: 10.1016/j.cmi.2026.01.029. Epub[...]